Ultraleap, a renowned global leader in hand-tracking and immersive interaction technologies, has recently introduced the Helios Development Kit. This groundbreaking kit marks a significant milestone in the realm of smart glasses interaction, as it combines event-based vision sensing with microgesture recognition technology.
The Helios Development Kit is the first of its kind to merge Prophesee’s GENX320 event camera with advanced micro-gesture capabilities through the Helios SDK. This fusion enables users to control content and applications on smart glasses through intuitive gestures, revolutionizing the way we interact with wearable technology.
Key Takeaways from the Helios Development Kit Launch:
1. Ultraleap has unveiled the world’s first development kit to combine Prophesee’s event camera and advanced micro-gesture technology, enabling gesture control for smart glasses content and applications.
2. The launch of the Helios Pilot Programme offers a unique opportunity for developers to secure one of the limited Helios development kits and be among the first to harness this innovative technology.
3. The Helios Development Kit offers low latency, low power consumption, and high dynamic range, making it ideal for attaching to smart glasses for always-on interactions.
The Helios Pilot Programme:
Ultraleap is inviting specialized researchers and industry experts to participate in shaping the future of this revolutionary technology through the Helios Pilot Programme. Members will receive their own Helios Development Kit and have the chance to contribute directly to the product development journey.
Tom Carter, CEO and Co-Founder of Ultraleap, expressed excitement about collaborating with industry and academia to redefine human-computing interaction through the Helios Development Kit.
Unlocking New Possibilities with Helios SDK:
The Helios Development Kit includes an alpha version of the Helios SDK, allowing developers to access supported microgestures like right swipe, left swipe, and double pinch. Luca Verre, CEO, and Co-Founder of Prophesee highlighted the breakthrough applications in AR/VR and IoT enabled by event-based vision technology.
Join the World’s Greatest Interaction Pioneers:
By joining the Helios Pilot Programme, developers and researchers can secure a spot at the forefront of gesture interaction technology. Members will receive a Helios Development Kit and gain direct access to Ultraleap’s research team to shape the future of event-based interaction technologies.
CES 2025 Showcase:
Ultraleap will showcase its technology at CES 2025, scheduled from January 7-11, 2025. To schedule a demo, interested parties can contact Ultraleap via email.
In conclusion, Ultraleap’s Helios Development Kit represents a significant advancement in smart glasses interaction technology. By combining event-based vision sensing with microgesture recognition, Ultraleap is paving the way for seamless and intuitive interactions with wearable devices. Developers and researchers interested in exploring the possibilities of this innovative technology can register their interest in the Helios Pilot Programme. The COVID-19 pandemic has brought about unprecedented challenges and changes to our daily lives. From lockdowns and social distancing measures to the widespread adoption of remote work and online schooling, the pandemic has forced us to adapt to a new normal. One of the most significant changes that has taken place during this time is the rise of telemedicine.
Telemedicine, also known as telehealth, is the provision of healthcare services remotely through the use of technology. This can include video consultations, phone calls, and even messaging apps. Telemedicine has become increasingly popular during the pandemic as it allows patients to receive medical care without having to leave their homes, reducing the risk of exposure to the virus.
One of the main advantages of telemedicine is its convenience. Patients no longer have to travel to a doctor’s office or wait in a crowded waiting room. Instead, they can simply log on to a video call with their healthcare provider from the comfort of their own home. This not only saves time and money but also makes healthcare more accessible to those who may have difficulty traveling to a doctor’s office, such as the elderly or disabled.
Telemedicine has also helped to alleviate the strain on healthcare systems by reducing the number of people visiting hospitals and clinics for non-emergency issues. This has allowed healthcare providers to focus their resources on treating COVID-19 patients and other urgent cases. Additionally, telemedicine has helped to prevent the spread of the virus by allowing patients to receive medical care without coming into contact with others.
Despite its many benefits, telemedicine also has its limitations. For example, some medical conditions may require an in-person examination or tests that cannot be done remotely. Additionally, not all patients may have access to the necessary technology or internet connection to participate in telemedicine appointments.
As the pandemic continues to evolve, it is likely that telemedicine will become an even more integral part of the healthcare system. Many healthcare providers have already invested in telemedicine technology and have seen positive results in terms of patient satisfaction and outcomes. As more people become accustomed to receiving healthcare remotely, telemedicine may become a permanent fixture in the way we access medical care.
In conclusion, telemedicine has emerged as a valuable tool during the COVID-19 pandemic, allowing patients to receive medical care remotely and reducing the strain on healthcare systems. While it may not be suitable for all medical conditions, telemedicine has the potential to revolutionize the way we access healthcare in the future. As technology continues to advance, it is likely that telemedicine will become an increasingly important part of the healthcare landscape.